Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Aaron Schuchart currently holds 12,000 shares of Aeglea BioTherapeutics, Inc. (AGLE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Aaron Schuchart has been a net seller of AGLE stock. They have purchased $14.8K and sold $57.0K worth of shares.
Aaron Schuchart's most recent insider trade was on Dec 12, 2024, when they sold 8,500 shares at $0.00 per share.
Aaron Schuchart serves as Executive at Aeglea BioTherapeutics, Inc. (AGLE). They have executed 18 insider transactions totaling $71.8K over their tenure at the company.
Aaron Schuchart holds the position of Executive at Aeglea BioTherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Aaron Schuchart has shown a selling trading pattern, with $14.8K in total purchases and $57.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Aaron Schuchart was on Sep 27, 2018, when they sold $56.0K worth of AGLE shares. This transaction involved 5,900 shares at $9.50 per share.
Aaron Schuchart currently owns 12,000 shares of Aeglea BioTherapeutics, Inc. (AGLE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Aaron Schuchart's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Aaron Schuchart has 18 Form 4 filings on record as an insider at Aeglea BioTherapeutics, Inc..
Set alerts for Aaron Schuchart and 40,000+ other insiders.